Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 3Phase 2 3Phase 4 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 3Thoracic 1Other 1Classical hematology 1Breast 1

Conditions

Ovarian Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

olaparib 6Specimen Handling 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 4Carboplatin 4pembrolizumab 3fludarabine 3X-Rays 3Taxes 3Metformin 3Letrozole 3Fluorodeoxyglucose F18 3Biopsy 3Aspirin 3niraparib 2Tirzepatide 2Radiotherapy 2Propranolol 2Platinum 2Pafolacianine 2Oncolytic Virotherapy 2Hysterectomy 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorescein 2Drug Therapy 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Aspirin × Gynecologic × Clear all
NCT05080946 2026-04-01

Using Aspirin to Improve Immunological Features of Ovarian Tumors

H. Lee Moffitt Cancer Center and Research Institute

Phase EARLY_PHASE1 Recruiting
100 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03771651 2026-02-17

Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube

University of Oklahoma

Phase EARLY_PHASE1 Active not recruiting
18 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT03378297 2024-10-30

IMPACT

Haukeland University Hospital

Phase EARLY_PHASE1 Completed
26 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡